Literature DB >> 21317619

Combination use of a TandemHeart with an extracorporeal oxygenator in the treatment of five patients with refractory cardiogenic shock after acute myocardial infarction.

Yat Wa Li1, Warren D Rosenblum, Alan L Gass, Melvin B Weiss, Wilbert S Aronow.   

Abstract

Cardiogenic shock remains the leading cause of in-hospital death for patients admitted with acute myocardial infarction. For patients with refractory cardiogenic shock, early revascularization and intra-aortic balloon pump support are often inadequate to reverse the persistent circulatory collapse. We report 5 cases in which an extracorporeal oxygenator in series with the TandemHeart system was instituted emergently in patients with refractory cardiogenic shock from acute myocardial infarction. From our experience, we showed that the device can be safely and easily inserted and that it is able to reverse circulatory collapse and provide hemodynamic stability in patients who otherwise have a high mortality rate.

Entities:  

Mesh:

Year:  2013        PMID: 21317619     DOI: 10.1097/MJT.0b013e3182068db7

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  4 in total

Review 1.  Hybrid extracorporeal membrane oxygenation.

Authors:  Alexandre Brasseur; Sabino Scolletta; Roberto Lorusso; Fabio Silvio Taccone
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 2.  Use of left ventricular support devices during acute coronary syndrome and percutaneous coronary intervention.

Authors:  Jon Spiro; Sagar N Doshi
Journal:  Curr Cardiol Rep       Date:  2014-12       Impact factor: 2.931

Review 3.  Mechanical Circulatory Support for Acute Heart Failure Complicated by Cardiogenic Shock.

Authors:  Min Suk Choi; Hunbo Shim; Yang Hyun Cho
Journal:  Int J Heart Fail       Date:  2020-01-22

Review 4.  Left ventricular decompression in veno-arterial extracorporeal membrane oxygenation.

Authors:  Ashleigh Xie; Paul Forrest; Antonio Loforte
Journal:  Ann Cardiothorac Surg       Date:  2019-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.